DK1411992T3 - Ioniske og ikke-ioniske, radiografiske kontrastmidler til anvendelse ved kombineret röntgenstråle- og kernemagnetisk resonansdiagnostik - Google Patents

Ioniske og ikke-ioniske, radiografiske kontrastmidler til anvendelse ved kombineret röntgenstråle- og kernemagnetisk resonansdiagnostik

Info

Publication number
DK1411992T3
DK1411992T3 DK02758379T DK02758379T DK1411992T3 DK 1411992 T3 DK1411992 T3 DK 1411992T3 DK 02758379 T DK02758379 T DK 02758379T DK 02758379 T DK02758379 T DK 02758379T DK 1411992 T3 DK1411992 T3 DK 1411992T3
Authority
DK
Denmark
Prior art keywords
ionic
ray
combined
magnetic resonance
nuclear magnetic
Prior art date
Application number
DK02758379T
Other languages
Danish (da)
English (en)
Inventor
Silvio Aime
Alessandro Barge
Valentina Mainero
Original Assignee
Bracco Imaging Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bracco Imaging Spa filed Critical Bracco Imaging Spa
Application granted granted Critical
Publication of DK1411992T3 publication Critical patent/DK1411992T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1806—Suspensions, emulsions, colloids, dispersions
    • A61K49/1812—Suspensions, emulsions, colloids, dispersions liposomes, polymersomes, e.g. immunoliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0461—Dispersions, colloids, emulsions or suspensions
    • A61K49/0466—Liposomes, lipoprotein vesicles, e.g. HDL or LDL lipoproteins, phospholipidic or polymeric micelles

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
DK02758379T 2001-08-03 2002-07-23 Ioniske og ikke-ioniske, radiografiske kontrastmidler til anvendelse ved kombineret röntgenstråle- og kernemagnetisk resonansdiagnostik DK1411992T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2001MI001706A ITMI20011706A1 (it) 2001-08-03 2001-08-03 Agenti di contrasto radiografici ionici e non ionici, utilizzabili per l'indagine diagnostica combinata tramite raggi-x e risonanza magnetic
PCT/EP2002/008183 WO2003013616A1 (en) 2001-08-03 2002-07-23 Ionic and non-ionic radiographic contrast agents for use in combined x-ray and nuclear magnetic resonance diagnostics

Publications (1)

Publication Number Publication Date
DK1411992T3 true DK1411992T3 (da) 2007-04-10

Family

ID=11448229

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02758379T DK1411992T3 (da) 2001-08-03 2002-07-23 Ioniske og ikke-ioniske, radiografiske kontrastmidler til anvendelse ved kombineret röntgenstråle- og kernemagnetisk resonansdiagnostik

Country Status (9)

Country Link
US (1) US8211404B2 (ja)
EP (1) EP1411992B1 (ja)
JP (1) JP4310187B2 (ja)
AT (1) ATE347912T1 (ja)
DE (1) DE60216770T2 (ja)
DK (1) DK1411992T3 (ja)
ES (1) ES2278946T3 (ja)
IT (1) ITMI20011706A1 (ja)
WO (1) WO2003013616A1 (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005087272A2 (en) 2004-03-11 2005-09-22 Mallinckrodt Inc. X-ray contrast formulation comprising a mixture of iodinated monomer and dimer
DE102005028882A1 (de) * 2005-06-22 2007-01-04 Siemens Ag Lösung und Verfahren zum Unterstützen der Bildgebung an einem Patienten
EP1907873B1 (en) * 2005-07-21 2015-02-25 Johns Hopkins University Non-invasive mri measurement of tissue glycogen
EP2073723A4 (en) * 2006-10-10 2011-03-30 Mayo Foundation REDUCTION OF TOXICITY INDUCED BY A CONTRAST AGENT
WO2009047316A1 (en) * 2007-10-12 2009-04-16 Ge Healthcare As Contrast agents
US8323619B2 (en) * 2007-11-07 2012-12-04 Ge Healthcare As Contrast agents
DE102007058220A1 (de) 2007-12-03 2009-06-04 Bayer Schering Pharma Aktiengesellschaft Dimere macrocyclisch substituierte Benzolderivate
EP2231200A1 (en) * 2007-12-05 2010-09-29 GE Healthcare AS Contrast agents
EP2245003A2 (en) * 2008-02-27 2010-11-03 GE Healthcare AS Contrast agents
EP2243767A1 (en) * 2009-04-21 2010-10-27 Bracco Imaging S.p.A Process for the iodination of aromatic compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2541272A1 (fr) * 1983-02-23 1984-08-24 Guerbet Sa Composes bromes et produits opacifiants en contenant
CA2187427A1 (en) * 1995-02-24 1996-08-29 Herve Tournier Liposome suspensions as blood pool imaging contrast agents
US5648536A (en) * 1995-06-07 1997-07-15 Dunn; Thomas Jeffrey Process for producing ioversol
RU2207808C2 (ru) * 1998-04-09 2003-07-10 Амершем Хелт АС Применение контрастных агентов в форме частиц в диагностической визуализации для изучения физиологических параметров
EP2025350A3 (en) * 1999-04-21 2009-12-09 The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services Determining pH by CEDST MRI
FR2794744B1 (fr) 1999-06-09 2001-09-21 Guerbet Sa Complexes metalliques de polyaminoacides bicycliques, leur procede de preparation et leur application en imagerie medicale

Also Published As

Publication number Publication date
WO2003013616A1 (en) 2003-02-20
EP1411992B1 (en) 2006-12-13
JP2005505527A (ja) 2005-02-24
ATE347912T1 (de) 2007-01-15
JP4310187B2 (ja) 2009-08-05
WO2003013616A8 (en) 2004-04-08
DE60216770T2 (de) 2007-04-12
US8211404B2 (en) 2012-07-03
ITMI20011706A1 (it) 2003-02-03
ITMI20011706A0 (it) 2001-08-03
ES2278946T3 (es) 2007-08-16
DE60216770D1 (de) 2007-01-25
US20050113675A1 (en) 2005-05-26
EP1411992A1 (en) 2004-04-28

Similar Documents

Publication Publication Date Title
NO991688L (no) Administrerbare sammensetninger og fremgangsmÕter til magnetisk resonansavbildning
TW200512006A (en) A method for making a magnetic resonance (MR) imaging agent, a mr imaging contrast agent, a metnod for altering stability of a peptide and a modified peptide
DK1411992T3 (da) Ioniske og ikke-ioniske, radiografiske kontrastmidler til anvendelse ved kombineret röntgenstråle- og kernemagnetisk resonansdiagnostik
ATE375118T1 (de) Patientenlagerungsgerät für ein medizinisches bilderzeugungssystem mit vielfältigen betriebsarten
WO2007002109A3 (en) Multidentate pyrone-derived chelators for medicinal imaging and chelation
DK1472541T3 (da) Afbildningsmidler og metoder til at afbilde NAALADase og PSMA
ATE349446T1 (de) Amyloid plaque aggregationshemmer und diagnostische bilderzeugungsmittel
IL180896A (en) Method @ Separation @ between @ tissue @ cancer and cancer using @ magnetic resonance imaging
IS4790A (is) Málmsamstæður sem innihalda Perflúoróalkýl og notkun þeirra við segulsneiðmyndunar-greiningar
TR199800610A3 (tr) Toplam nükleer manyetik rezonans porozite (gözeneklilik) ölçümü için yöntem ve alet.
EA200100571A1 (ru) Комбинированный способ лечебного воздействия, включающий применение лучевой терапии и ингибитора циклооксигеназы-2(cox-2) для лечения неоплазии
DE602005018035D1 (de) Magnetstruktur für eine mri-vorrichtung und mri-vorrichtung
DK2298362T3 (da) Reagerende paramagnetiske kontrastmidler til magnetresonansbilledteknik
ITMI20011708A0 (it) Coniugati di peptidi, loro derivati con complessi metallici e utilizzo per i'indagine diagnostica tramite imaging per risonanza magnetica(m
ATE187340T1 (de) Kontrastmittel
DE69120826T2 (de) Chelatbildende mittel
ES2117670T3 (es) Derivado de hidroxamato e hidrazida de poliaminas y su uso medico como agentes quelantes.
BR9508435A (pt) Quelentes macrocíclicos seus quelatos e usos dos mesmos no campo diagnóstico
DK1406927T3 (da) Glycopeptider, fremstilling og anvendelse deraf til diagnosticering eller terapeutisk behandling af dissemineret sklerose
DK1169058T3 (da) Insulinlignende vækstfaktorbindingsprotein-4-protease
ITSV980069A0 (it) Gabbia di faraday, in particolare per applicazioni in risonanza magnetica nucleare.
AU2002325358A1 (en) Ionic and non-ionic radiographic contrast agents for use in combined x-ray and nuclear magnetic resonance diagnostics
ITSV980068A0 (it) Gabbia di faraday, in particolare per applicazioni in risonanza magnetica nucleare.
ITPA20000015A0 (it) Apparecchio per la termoterapia accoppiata ad imaging della risonanzamagnetica nucleare o della tomografia assiale computerizzata.
Moore Ark. joint venture planned.